En español
NIDA

Menu

NIDA Notes Articles: Global Health

NIDA Notes Category Graphic

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

October 2007
Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.

NIDA Notes Category Graphic

Linking NIDA to Researchers on a Global Scale

June 2008

Highlights the NIDA International Program which works to strengthen international research networks, creating opportunities for global research collaboration, training, and scientific exchange.

NIDA Notes Category Graphic

United States Ranks First in Lifetime Use of Three Drugs

November 2009

Highlights the disproportionately high rate of Americans who have used cocaine at some time during their lives as compared with other nations surveyed.

NIDA Notes Category Graphic

Study Gives Green Light to Antiretroviral Medications for HIV-Infected Injection Drug Users

December 2009

Reports finding from a study showing that access to antiretroviral therapies, HAART in particular, can improve the health of HIV-infected patients who have a history of injection drug use.

NIDA Notes Category Graphic

James A. Inciardi (1939-2009)

April 2010
Remembers Dr. James A. Inciardi, founder and co-director of the Center for Drug and Alcohol Studies and professor at the University of Delaware, who died on November 23, 2009.

NIDA Notes Category Graphic

Injection Drug Users Acquire Hepatitis C Infection Later in Developed Countries

April 2010
Reports trends in onset of injection drug use to infection with hepatitis C virus in developed countries and notes the influence of prevention efforts.

NIDA Notes Category Graphic

Seek-Test-Treat-Retain To Stop the Spread of HIV

February 2013

Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

NIDA Notes Category Graphic

Naltrexone Implant Outperforms Daily Pill in Russian Trial

November 2013

More than half of heroin-addicted patients treated with naltrexone via an implanted delivery device maintained abstinence throughout a 6-month clinical trial in Saint Petersburg, Russia. The implant device, which releases a steady dose of naltrexone continuously for 2 months, averted relapse to heroin use three times as effectively as daily oral doses of the medication.

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics